After India reported a new record high of 2.73 lakh cases today, the government
has announced that members above 18 years of age will be eligible for Covid-19
vaccinations from May 1.
Covid-19 vaccinations will be made available to all those above eighteen years of age in the next stage beginning from May 1 of this month. This government made this announcement today after a series of meetings with the Prime Minister (PM) Narendra Modi. Addressing the public, PM Modi also said: “Government has been working hard for over a year to ensure that maximum numbers of Indians are able to get the vaccine in the shortest possible time (sic).”
In a public statement, the government said: all eligible members will be vaccinated in “a liberalized and accelerated Phase 3 strategy of COVID-19 vaccination”. This was followed by India reporting an unprecedented high of 2.73 cases in a single day. Up until now, the government had only allowed vaccinations for frontline workers and those above 45 years of age. The initial stage of the vaccination drive had started in January, using two Covid-19 vaccines – Serum Institute of India’s Covisheild developed by Oxford-AstraZeneca and Bharat Biotech made-in-India Covaxin. The government has made promises to ensure that the pricing, procurement, eligibility and administering of vaccines will be flexible in the latest stage of ‘the world’s largest vaccination drive’. Manufacturers have been incentivized to scale up their production and release upto 50 per cent of their supply to the state governments as well as the open markets at a declared price.
Read DU Beat’s take on Covid-19 here
These are some key points in the liberalized vaccination rules:
? Vaccine manufacturers will supply 50 per cent of their monthly Central
Drugs Laboratory (CDL) released doses to the central government and will
be free to supply the remaining 50% doses to state governments and in the
? Manufacturers will declaration prices in advance for the vaccines supplied
to state governments and in open market.
? Based on this price, state governments, private hospitals, industrial
establishments can buy vaccine doses from the manufacturers.
? Vaccinations at central government centres, provided free of cost, will
continue for previous categories – health workers, frontline workers and
those above 45.
? The Centre will allocate vaccines from its share to States or Union
Territories based on the number of cases. Vaccine wastage can affect the
quota of a state.
? The second dose for existing priority groups will be priority
Featured Image Credits: Asian Development Blog